Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-01-25

FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for Fosamax Plus D (alendronate sodium with cholecalciferol) from Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosamax Plus D (Alendronate Sodium and Cholecalciferol)

Snippet

SUPPL AP for FOSAMAX PLUS D (ALENDRONATE SODIUM AND CHOLECALCIFEROL)